Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4330783 | 0.74 | MAPT (0.41) | KDM4EUSP2TP53CYP3A4MAPT | |
| SCHEMBL9229136 | 0.74 | CTSB (0.34) | CYP3A4MAPT | |
| SCHEMBL5706407 | 0.72 | MAPT (0.31) | KDM4EUSP2TP53CYP3A4MAPT | |
| SCHEMBL3139264 | 0.68 | MAPT (0.37) | KDM4EUSP2TP53CYP3A4MAPT | |
| Ammonia Solution, Strong SCHEMBL8821900 | 0.67 | MAPT (0.36) | KDM4EUSP2TP53CYP3A4MAPT | |
| SCHEMBL7266307 | 0.62 | MAPT (0.49) | KDM4ETP53MAPTMAPK1 | |
| SCHEMBL9131663 | 0.60 | HPGD (0.33) | MAPT | |
| SCHEMBL29369406 | 0.60 | DRD2 (0.34) | CYP3A4MAPT | |
| Sulfuric Acid SCHEMBL29371328 | 0.59 | DRD2 (0.33) | MAPT | |
| SCHEMBL13397817 | 0.59 | ALDH1A1 (0.37) | KDM4EUSP2TP53CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0678774-A2 | Deposition sensitized emulsions | EASTMAN KODAK COMPANY (US) | 1995-10-25 | — | — | EP | disclosed |